Ibotta was founded in 2011 by Bryan Leach. According to Bloomberg, in November 2023 Ibotta announced plans for an IPO valued at $2 billion. The company has not officially announced an IPO date, however, there is anticipation for a 2024 IPO.
Ibotta is a mobile software application that offers cashback rewards by enabling online retailer deals to consumers. Per Forge data, Ibotta has raised $92.9 million in funding over 6 rounds, with their latest funding raised on Aug 6, 2019, from a Series D round. Key investors include GGV Capital, Koch Disruptive Technologies, and Teamworthy Ventures.
These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
08/06/2019 | Series D | $150MM | $xx.xx | $100.14B | Koch Disruptive Technologies | |
Price per Share
$xx.xx
Shares Outstanding
4,151,214
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Koch Disruptive Technologies
|
||||||
07/25/2017 | Series C-1 | $24.98MM | $xx.xx | $34.54B | Fj Labs, Ggv Capital, Harbor Spring Capital, James Clark, Teamworthy Ventures, Thomas Jermoluk | |
Price per Share
$xx.xx
Shares Outstanding
1,578,552
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Fj Labs, Ggv Capital, Harbor Spring Capital, James Clark, Teamworthy Ventures, Thomas Jermoluk
|
||||||
10/01/2015 | Series C | $38.32MM | $xx.xx | $24.31B | Jim Clark | |
Price per Share
$xx.xx
Shares Outstanding
3,300,548
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Jim Clark
|
||||||
06/17/2014 | Series B | $20MM | $xx.xx | $9.55B | Cbshealthwatch, Greak Oaks Venture Capital, Jim Clark | |
Price per Share
$xx.xx
Shares Outstanding
3,824,091
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Cbshealthwatch, Greak Oaks Venture Capital, Jim Clark
|
||||||
05/02/2013 | Series A | $8.14MM | $xx.xx | $5.14B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
1,984,186
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
03/15/2012 | Series Seed | $1.78MM | $xx.xx | $508.99MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
2,407,363
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|